To avoid problems arising from the tissue fixation and paraffin embedding, we used cell cultures-derived DNA for detection of SLC22A18 promoter methylation satus; and MSP was performed comparably from tumor cells and snap-frozen tissue in a subgroup of tumors, confirming the presence of methylated SLC22A18 promoter sequences in all cases. Here, SLC67A1 is linked to neoplasm.